TORONTO -- (MARKET WIRE) -- September 18, 2006 -- Generex Biotechnology Corporation (NASDAQ: GNBT), the leader in metabolic diseases drug delivery through the inner lining of the mouth, announced today that Cardinal Health will distribute its new Glucose RapidSpray™ product in the U.S.
